CDEK by Data4ThePeople

Sign in Sign up

← All organizations

Ocumension Therapeutics (Shanghai) Co., Ltd

For profit

Also known as: Ocumension Therapeutics (Shanghai) Co., Ltd | Ocumension Therapeutics (Suzhou) Co., Ltd

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

Jun 25, 2023

Timeline

2010s

Jan 1, 2017
Ocumension Therapeutics (Shanghai) Co., Ltd— Founded

Drugs by trial phase (3 distinct, 4 trials)

Phase 4 (1 own, 0 via acquisition)

urea

Phase 3 (1 own, 0 via acquisition)

atropine

Phase 2 (1 own, 0 via acquisition)

ot202

Recent trials (6)

NCT06697522Lead sponsorPhase 3Jun 25, 2023
NCT06435182Lead sponsorPhase 2Apr 10, 2023
NCT06429306OfficialPhase 3Aug 22, 2022
NCT06429306Lead sponsorPhase 3Aug 22, 2022
NCT06497699OfficialPhase 4Oct 28, 2021
NCT06497699Lead sponsorPhase 4Oct 28, 2021

Details

Founded: Shanghai, CN Jan 1, 2017
Last known activity: Jun 25, 2023